BioSpace News Archive

The Annual General Meeting of Nordic Nanovector ASA was held 30 May in Oslo, Norway.

Oragenics, Inc. (NYSE American: OGEN), a leader in the development of new antibiotics against infectious diseases and effective treatments for oral mucositis (OM), today announced positive results from its interim safety analysis as requested by FDA on patients from its Phase 2 clinical trial of AG013 for the treatment of OM.

Centene Corporation announced it will present at the Goldman Sachs 39th Annual Global Healthcare Conference.

AbbVie today announced the preliminary results of its modified Dutch auction tender offer.

Geom Therapeutics, Inc. announced upcoming data presentations at the American Society of Microbiologists (ASM) Microbe 2018 Annual Meeting.

AMRI’s Michele Luche, vice president, Discovery Services, will be participating in a panel discussion on bridging the gap between early promise and clinic-ready compounds at the 2018 BIO International Convention.

Elstar Therapeutics announced the formation of its scientific advisory board, comprised of leaders in immunology and cancer research.

Syros Pharmaceuticals announced that its Chief Executive Officer Nancy Simonian, M.D., will present a corporate overview at upcoming investor conferences.

Parvus is advancing a therapeutic pipeline of novel class of disease-modifying therapeutics – Navacims™ – toward clinical testing for the treatment of diverse autoimmune diseases

Imara Inc. today announced additions to its clinical development team with the appointments of Joe Datt, M.D., as Senior Vice President, Clinical Development, and Siddharth Parulkar as Head, Global Clinical Operations.